Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice.

Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Abstract Text:

    koji uranoKoji Urano,shuzo suzukiShuzo Suzuki,kazuhiko machidaKazuhiko Machida,natsuko eguchiNatsuko Eguchi,nobuko sawaNobuko Sawa,koji kikuchiKoji Kikuchi,yuji hattoriYuji Hattori,toshimi usuiToshimi Usui,koji uranoKoji Urano,shuzo suzukiShuzo Suzuki,kazuhiko machidaKazuhiko Machida,natsuko eguchiNatsuko Eguchi,nobuko sawaNobuko Sawa,koji kikuchiKoji Kikuchi,yuji hattoriYuji Hattori,toshimi usuiToshimi Usui,

    We examined the possibility of expanding applications of rasH2 mice, which are genetically manipulated mice for short-term carcinogenicity tests, to percutaneous application. A 26-week short-term carcinogenicity study was performed on a total of 300 mice including 75 male and female rasH2 mice each, and 75 male and female non-Tg mice each from the same litter as the rasH2 mice divided into untreated group, an ethanol group, a white Vaseline group, an acetone group, and a phorbol 12-myristate 13-acetate (TPA) group. Only shaving of dorsal skin was performed on the untreated mice. As a positive control, TPA was administered percutaneously at a dose of 2.5 microg/kg and 3 times/week for 26 weeks based on the protocol for Tg.AC mice in the ILSI/HESI international validation study. In the ethanol, white Vaseline, and acetone groups, no tumorous changes were observed on the skin at the administration site. In the TPA group, nodular changes at the administration site were observed from seven weeks after the start of administration in rasH2 mice, and the incidence in males and females was 50.0% (7/14) and 53.3% (8/15), respectively. In a pathological examination, nodules in 21.4% (3/14) of males and 46.7% (7/15) of females were diagnosed as skin papilloma or keratoacanthoma, and the rest as squamous cell hyperplasia. In the non-Tg mice, no nodules or tumorigenic changes were observed at the administration site. These findings show that percutaneous application in rasH2 mice is possible in 26-week carcinogenicity tests.

    Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Publishing Authors By Initials

    k uranoK Urano,s suzukiS Suzuki,k machidaK Machida,n eguchiN Eguchi,n sawaN Sawa,k kikuchiK Kikuchi,y hattoriY Hattori,t usuiT Usui,k uranoK Urano,s suzukiS Suzuki,k machidaK Machida,n eguchiN Eguchi,n sawaN Sawa,k kikuchiK Kikuchi,y hattoriY Hattori,t usuiT Usui,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of toxicological sciences

    VOLUME: 32

    Page Numbers: 367-75

    Journal Abbreviation:

    ISSN: 0388-1350

    DAY: 29

    MONTH: Oct

    YEAR: 2007

    Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7805798

    Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice.

    AFFILIATION: Central Institute for Experimental Animals, Kawasaki, Japan.

    Country: Japan

    Japan Research PublicationJapan Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Toxicol Sci

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News